EAM Investors, LLC - VAXCYTE INC ownership

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of VAXCYTE INC
ValueSharesWeighting
Q3 2023$881,393
-70.9%
17,289
-71.4%
0.17%
-69.6%
Q2 2023$3,024,067
+61.8%
60,554
+21.4%
0.56%
+52.6%
Q1 2023$1,868,865
-39.9%
49,863
-23.1%
0.37%
-42.9%
Q4 2022$3,108,35964,8250.64%
Other shareholders
VAXCYTE INC shareholders Q4 2023
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 1,457,300$54,619,60423.40%
Pivotal bioVenture Partners Investment Advisor LLC 693,039$25,975,10210.70%
RA Capital Management 7,291,254$273,276,2006.19%
Kynam Capital Management, LP 1,216,784$45,605,0645.89%
GREAT POINT PARTNERS LLC 659,211$24,707,2284.85%
Frazier Life Sciences Management, L.P. 1,397,405$52,374,7393.79%
ACUTA CAPITAL PARTNERS, LLC 120,500$4,516,3403.33%
Ghost Tree Capital, LLC 225,000$8,433,0002.49%
Carlyle Group Inc. 1,923,158$72,079,9622.15%
Opaleye Management Inc. 177,000$6,633,9601.99%
View complete list of VAXCYTE INC shareholders